N-[(1R,2R,6S,7S,8S,10R)-3,5-Dioxo-4-azatetracyclo[5.3.2.0~2,6~.0~8,10~]dodec-11-en-4-yl]-4-(trifluoromethyl)benzamide(CAS: 816458-31-8)

The compound N-[(1R,2R,6S,7S,8S,10R)-3,5-Dioxo-4-azatetracyclo[5.3.2.0~2,6~.0~8,10~]dodec-11-en-4-yl]-4-(trifluoromethyl)benzamide (CAS: 816458-31-8) falls under the scope of several regulatory guidelines. It is subject to the REACH regulations in the European Union, which require documentation of its potential environmental, health, and safety impacts. Additionally, it must comply with the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) for proper hazard communication. In the United States, it is regulated by the EPA and FDA for environmental and pharmaceutical applications, respectively. Compliance with these guidelines is essential for safe handling and use.

Several alternatives to N-[(1R,2R,6S,7S,8S,10R)-3,5-Dioxo-4-azatetracyclo[5.3.2.0~2,6~.0~8,10~]dodec-11-en-4-yl]-4-(trifluoromethyl)benzamide (CAS: 816458-31-8) exist in synthesis. For example, related compounds such as trifluoromethylated benzamides with different substituents can be used as effective alternatives. Additionally, analogous compounds with similar structural features, such as other azatetracyclic benzamides, can serve as viable options. Care should be taken to ensure that these alternatives meet the necessary regulatory and safety requirements.

The market and research trends for N-[(1R,2R,6S,7S,8S,10R)-3,5-Dioxo-4-azatetracyclo[5.3.2.0~2,6~.0~8,10~]dodec-11-en-4-yl]-4-(trifluoromethyl)benzamide (CAS: 816458-31-8) are currently focused on its potential applications in pharmaceutical and chemical research. There is a growing interest in its use as an intermediate in the synthesis of complex organic molecules, particularly in the development of new drugs. Additionally, there is a trend towards exploring the catalytic properties and reactivity of this compound in various synthetic pathways. The demand for this compound is expected to increase as more applications are discovered and validated.

Waste containing N-[(1R,2R,6S,7S,8S,10R)-3,5-Dioxo-4-azatetracyclo[5.3.2.0~2,6~.0~8,10~]dodec-11-en-4-yl]-4-(trifluoromethyl)benzamide (CAS: 816458-31-8) should be handled according to the specific regulations of the country or region. Generally, such waste should be collected in sealed, labeled containers and disposed of through a licensed hazardous waste facility. The waste should be neutralized or treated to reduce its toxicity before disposal. Environmental protection measures include ensuring proper ventilation and the use of personal protective equipment. It is crucial to follow local and international waste disposal guidelines to prevent environmental contamination and ensure safety.